Lionel Messi's Childhood Growth Hormone Treatment

Diagnosis and daily treatment

In January 1997, Newell's Old Boys referred Lionel Messi to pediatric endocrinologist Diego Schwarzstein in Rosario, Argentina.^[1] Messi was nine years old and already conspicuously skilled with a football, but he was also unusually short for his age. Schwarzstein later said he followed the ordinary diagnostic process used for a child with restricted growth, ruling out other possible causes before identifying a partial deficiency of growth hormone.^[1] Treatment with recombinant human growth hormone followed. The underlying event is well documented, although later accounts disagree about Messi's exact age when the diagnosis and injections began.

Growth hormone deficiency is not simply another name for being short. Growth hormone is produced by the pituitary gland and helps regulate childhood growth. The Pediatric Endocrine Society notes that diagnosis cannot be made from one random measurement because the hormone is released in pulses.^[5] Specialists instead consider the child's growth pattern, related laboratory measurements and, when appropriate, stimulation tests and imaging. In Messi's case, no public medical chart permits an independent reconstruction of every test. The most direct clinical account is Schwarzstein's description of evaluating him and prescribing replacement for a confirmed deficiency.

Why follow-up mattered

The Pediatric Endocrine Society describes treatment as a continuing clinical process: specialists assess growth and adjust the dose, rather than prescribing a fixed course from a single height measurement.^[5] That explains why dependable access over several years mattered in this case. Public interviews establish treatment history; they cannot substitute for confidential monitoring records.

The standard treatment at the time was a small injection of manufactured growth hormone under the skin each day, with the dose adjusted as a child gained weight and entered puberty. Messi said in a 2018 television interview that his parents initially gave the injections and that he later learned to do it himself, alternating legs each night.^[2] He remembered starting at about eleven. That recollection does not align exactly with Schwarzstein's January 1997 date for the initial consultation and treatment process, when Messi was nine. Rather than force the two memories into a precise birthday, the defensible conclusion is that therapy began in late childhood and continued into his early teens.

Football, cost, and the move to Barcelona

The medical problem was identified after Messi's football ability was already evident. He had played at the neighborhood club Grandoli and then entered the youth system at Newell's. Schwarzstein remembered that the child's practical concern was whether his eventual height would allow him to become a professional player.^[1] The physician has repeatedly separated the treatment from Messi's sporting talent: its purpose was to correct a biological limitation, not to teach technique or manufacture athletic skill. That distinction matters because replacement therapy for a diagnosed deficiency aims to restore the growth signal a child's body is not producing adequately.

Paying for several years of therapy became increasingly difficult. Retellings often compress the story into a simple exchange in which Barcelona funded the entire course, but Schwarzstein offered a more qualified account in 2026. He said family health coverage and a mutual-aid organization paid most of the expense in Argentina, while Barcelona guaranteed continuity during the final stage and probably covered about one-fifth of the total treatment.^[1] Associated Press reporting confirms the broader point that financing was a serious obstacle and that Newell's did not take on the cost. Exact monthly figures vary across retrospective accounts, so they are less reliable than the consistent evidence that the expense strained the family's options.

Messi traveled to Barcelona for a trial in 2000 and entered the club's youth system at thirteen. The move joined two decisions that are sometimes told separately: Barcelona wanted an exceptional young footballer, and the Messi family needed a secure way to continue his medicine. In a 2010 interview, Messi said the club's willingness to pay for treatment was the decisive offer.^[3] The arrangement did not guarantee a professional career. It gave a child access to care while placing him in one of Europe's most demanding academies, far from much of his family and familiar life in Rosario.

What the medical record establishes

The clinical goal was normal development, not unlimited growth. Great Ormond Street Hospital describes pediatric replacement therapy as a way to return a child with growth hormone deficiency toward the growth curve expected from family height and other factors.^[6] Response differs from patient to patient and requires continuing specialist supervision. Later accounts commonly say Messi completed treatment in his mid-teens, but the available firsthand sources do not establish a universally agreed stopping date. Schwarzstein described a course lasting roughly four to five years, with Barcelona involved near its end.^[1] It is therefore safer to place completion in the early 2000s than to assign a particular age or day.

What survives in the public record is enough to confirm the essential history but not every popular detail. Messi had a medically diagnosed growth hormone deficiency, received prescribed recombinant hormone, learned to administer nightly injections, and moved to a club that helped keep the treatment available. The records do not support reducing his later career to the medicine, nor do they justify presenting ordinary replacement care as secret athletic enhancement. Treatment removed one preventable barrier; it did not predetermine what happened after he stepped onto the field. The episode is ultimately a history of pediatric diagnosis, sustained access to an expensive therapy, and a family decision that joined health care to sporting opportunity.